Literature DB >> 19370535

Isolation of hypoglycemic phytoconstituent from Swietenia macrophylla seeds.

Anup Maiti1, Saikat Dewanjee, Ranabir Sahu.   

Abstract

The present study was undertaken to isolate a novel antidiabetic molecule from Swietenia macrophylla seeds. The hydroalcohol extract of Swietenia macrophylla seeds was subjected for bioassay guided isolation employing glucose utilization assay by the isolated rat hemi-diaphragm method in vitro. One tetranortriterpenoid, swietenine, isolated from the chloroform fraction exhibited significant (p<0.01) activity and the effect was comparable to that of human insulin (p<0.01). Copyright (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370535     DOI: 10.1002/ptr.2821

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  Acute oral toxicity studies of Swietenia macrophylla seeds in Sprague Dawley rats.

Authors:  Madhu Katyayani Balijepalli; Velan Suppaiah; An-Me Chin; Ayuba Sunday Buru; Sreenivasa Rao Sagineedu; Mallikarjuna Rao Pichika
Journal:  Pharmacognosy Res       Date:  2015 Jan-Mar

Review 2.  Chemical Structures and Biological Activities of Limonoids from the Genus Swietenia (Meliaceae).

Authors:  Yun-Peng Sun; Wen-Fang Jin; Yong-Yue Wang; Gang Wang; Susan L Morris-Natschke; Jin-Song Liu; Guo-Kai Wang; Kuo-Hsiung Lee
Journal:  Molecules       Date:  2018-06-29       Impact factor: 4.411

Review 3.  The recent use of Swietenia mahagoni (L.) Jacq. as antidiabetes type 2 phytomedicine: A systematic review.

Authors:  Martha Ervina
Journal:  Heliyon       Date:  2020-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.